DK115333B - Fremgangsmåde til fremstilling af 3,5-dioxopyrazolidinderivater. - Google Patents

Fremgangsmåde til fremstilling af 3,5-dioxopyrazolidinderivater.

Info

Publication number
DK115333B
DK115333B DK589363AA DK589363A DK115333B DK 115333 B DK115333 B DK 115333B DK 589363A A DK589363A A DK 589363AA DK 589363 A DK589363 A DK 589363A DK 115333 B DK115333 B DK 115333B
Authority
DK
Denmark
Prior art keywords
preparation
dioxopyrazolidine
derivatives
dioxopyrazolidine derivatives
Prior art date
Application number
DK589363AA
Other languages
English (en)
Inventor
V Musil
B Brunova
O Nemecek
Z Horakova
Original Assignee
Spofa Vereinigte Pharma Werke
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spofa Vereinigte Pharma Werke filed Critical Spofa Vereinigte Pharma Werke
Publication of DK115333B publication Critical patent/DK115333B/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/28Two oxygen or sulfur atoms
    • C07D231/30Two oxygen or sulfur atoms attached in positions 3 and 5
    • C07D231/32Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/28Two oxygen or sulfur atoms
    • C07D231/30Two oxygen or sulfur atoms attached in positions 3 and 5
    • C07D231/32Oxygen atoms
    • C07D231/36Oxygen atoms with hydrocarbon radicals, substituted by hetero atoms, attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Catalysts (AREA)
DK589363AA 1962-12-19 1963-12-18 Fremgangsmåde til fremstilling af 3,5-dioxopyrazolidinderivater. DK115333B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CS712962 1962-12-19

Publications (1)

Publication Number Publication Date
DK115333B true DK115333B (da) 1969-09-29

Family

ID=5419846

Family Applications (1)

Application Number Title Priority Date Filing Date
DK589363AA DK115333B (da) 1962-12-19 1963-12-18 Fremgangsmåde til fremstilling af 3,5-dioxopyrazolidinderivater.

Country Status (10)

Country Link
US (1) US3328418A (da)
AT (1) AT244956B (da)
BE (1) BE641454A (da)
BR (1) BR6355534D0 (da)
DE (1) DE1470260A1 (da)
DK (1) DK115333B (da)
FI (1) FI44405B (da)
GB (1) GB1054862A (da)
NL (2) NL129209C (da)
SE (1) SE311521B (da)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2773880A (en) * 1955-09-23 1956-12-11 Synfarma Narodni Podnik Process for producing 4-substituted 1, 2-diaryl-3, 5-dioxo pyrazolidines
US3123616A (en) * 1960-05-27 1964-03-03 C o nxe

Also Published As

Publication number Publication date
NL302278A (da)
BE641454A (da)
DE1470260A1 (de) 1969-04-10
GB1054862A (da)
US3328418A (en) 1967-06-27
SE311521B (da) 1969-06-16
FI44405B (da) 1971-08-02
AT244956B (de) 1966-02-10
BR6355534D0 (pt) 1973-07-17
NL129209C (da)

Similar Documents

Publication Publication Date Title
DK117953B (da) Analogifremgangsmåde til fremstilling af p-aminoalkoxyphenylalkenderivater.
DK107749C (da) Fremgangsmåde til fremstilling af 5,6,7,7a,8,9-hexahydro-12-methyl-4aH-8,9c-iminoethanphenanthro-[4,5-b,c,d]-furanderivater.
DK114058B (da) Fremgangsmåde til fremstilling af 2,4-disulfamyl-N-(3-hydroxy-2-propenyliden)-anilinderivater.
DK105471C (da) Fremgangsmåde til fremstilling af 1,4-benzodiazepin-3H-forbindelser.
DK108971C (da) Fremgangsmåde til fremstilling af 6,17α -dimethylprogesteronderivater.
DK111447B (da) Fremgangsmåde til fremstilling af 17α-vinyl-5(10)-østren-17β-ol-3-on.
DK112306B (da) Fremgangsmåde til fremstilling af 2,6-dichlor-toluenderivater.
DK111487B (da) Fremgangsmåde til fremstilling af 17β-hydroxy- eller 17β-alkanoyloxy-3-keto-Δ<4,8(14),9>-gonatriener.
DK103081C (da) Fremgangsmåde til fremstilling af 2,6-diketo-8-thiapuriner.
DK115852B (da) Fremgangsmåde til fremstilling af 2,4-diamino-6-hydroxymethyl-7,8-dihydropteridin.
DK103025C (da) Fremgangsmåde til fremstilling af 1,4-dioxanderivater.
DK108682C (da) Fremgangsmåde til fremstilling af substituerede 9,10-dichlor-triphendioxazinfarvestoffer.
DK111175B (da) Fremgangsmåde til fremstilling af 4',19-diacylcymaroler.
DK104065C (da) Fremgangsmåde til fremstilling af 3-phenylgranaten-(2)-derivater.
DK104680C (da) Fremgangsmåde til fremstilling af derivater af 6-methyl-8-aminomethyl-ergolin I.
DK105161C (da) Fremgangsmåde til fremstilling af 3α-phenylgranatanderivater.
DK102920C (da) Fremgangsmåde til fremstilling af 1-cyancolchicinderivater.
DK122524B (da) Fremgangsmåde til fremstilling af 3,8-diazabicyklo-(3,2,1)-oktaner.
DK115333B (da) Fremgangsmåde til fremstilling af 3,5-dioxopyrazolidinderivater.
DK103513C (da) Fremgangsmåde til fremstilling af monomethonium- eller bis-methoniumforbindelser af 3-azabicyclo-(3,2,2)-nonanderivater.
DK116280B (da) Fremgangsmåde til fremstilling af 4,5-dehydro-3-keto-19-nor-steroider.
DK106330C (da) Fremgangsmåde til fremstilling af 16-halogenmethylen-17α-hydroxy-3,20-diketo-4,6-pregnadienderivater.
DK120747B (da) Fremgangsmåde til fremstilling af 13-alkylgona-1,3,5(10),8,14-pentaener.
DK98242C (da) Fremgangsmåde til fremstilling af 6,16-dimethyl-17α-hydroxy-3,20-diketo-4,6,15-pregnatrienderivater.
DK102964C (da) Fremgangsmåde til fremstilling af 4-oxo-6-sulfamyl-1,2,3,4-tetrahyrdoquinazolinonderivater.